Archives for April 21, 2010

← 2010

Provexis not concerned about reduced DSM stake

By Shane Starling

DSM Ventures decision to sell 33m shares and reduce its stake in UK biotech start-up Provexis from 20.8 to 17.8 per cent, represents profit-making rather than any kind of fire sale, according to an analyst.